Literature DB >> 30905380

Spectral CT and its specific values in the staging of patients with non-small cell lung cancer: technical possibilities and clinical impact.

U Fehrenbach1, J Kahn1, G Böning1, F Feldhaus1, K Merz1, N Frost2, M H Maurer3, D Renz4, B Hamm1, F Streitparth5.   

Abstract

AIM: To investigate how spectral computed tomography (SCT) values impact the staging of non-small cell lung cancer (NSCLC) patients.
MATERIALS AND METHODS: One hundred and thirteen patients with confirmed NSCLC were included in a prospective cohort study. All patients underwent single-phase contrast-enhanced SCT (using the fast tube voltage switching technique, 80-140 kV). SCT values (iodine content [IC], spectral slope pitch, and radiodensity increase) of malignant tissue (primary and metastases) and lymph nodes (LNs) were measured. Adrenal masses were evaluated in a virtual non-contrast series (VNS). If pulmonary embolism was present, pulmonary perfusion was analysed as an additional finding.
RESULTS: Fifty-two untreated primary NSCLC lesions were evaluable. Lung adenocarcinoma had significantly higher normalised IC (NIC: 19.37) than squamous cell carcinoma (NIC: 12.03; p=0.035). Pulmonary metastases were not significantly different from benign lung nodules. A total of 126 LNs were analysed and histologically proven metastatic LNs (2.08 mg/ml) had significantly lower IC than benign LNs (2.58 mg/ml; p=0.023). Among 34 adrenal masses, VNS identified adenomas with high sensitivity (91%) and specificity (100%). In two patients, a perfusion defect due to pulmonary embolism was detected in the iodine images.
CONCLUSION: SCT may contribute to the differentiation of histological NSCLC subtypes and improve the identification of LN metastases. VNS differentiates adrenal adenoma from metastasis. In case of pulmonary embolism, iodine imaging can visualise associated pulmonary perfusion defects.
Copyright © 2019 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.

Entities:  

Year:  2019        PMID: 30905380     DOI: 10.1016/j.crad.2019.02.010

Source DB:  PubMed          Journal:  Clin Radiol        ISSN: 0009-9260            Impact factor:   2.350


  5 in total

Review 1.  Application of Dual-Energy Spectral Computed Tomography to Thoracic Oncology Imaging.

Authors:  Cherry Kim; Wooil Kim; Sung Joon Park; Young Hen Lee; Sung Ho Hwang; Hwan Seok Yong; Yu Whan Oh; Eun Young Kang; Ki Yeol Lee
Journal:  Korean J Radiol       Date:  2020-07       Impact factor: 3.500

2.  Cost-effectiveness analysis of positron-emission tomography-computed tomography in preoperative staging for nonsmall-cell lung cancer with resected monometastatic disease.

Authors:  Xiaohui Zeng; Liubao Peng; Chongqing Tan; Yunhua Wang
Journal:  Medicine (Baltimore)       Date:  2019-08       Impact factor: 1.817

3.  Iodine-related attenuation in contrast-enhanced dual-energy computed tomography in small-sized solid-type lung cancers is associated with the postoperative prognosis.

Authors:  Shingo Iwano; Shinichiro Kamiya; Rintaro Ito; Shota Nakamura; Shinji Naganawa
Journal:  Cancer Imaging       Date:  2021-01-07       Impact factor: 3.909

4.  Dual-layer spectral detector computed tomography parameters can improve diagnostic efficiency of lung adenocarcinoma grading.

Authors:  Ronghua Mu; Zhuoni Meng; Zixuan Guo; Xiaoyan Qin; Guangyi Huang; Xuri Yang; Hui Jin; Peng Yang; Xiaodi Zhang; Xiqi Zhu
Journal:  Quant Imaging Med Surg       Date:  2022-09

5.  Effect of Reconstruction Algorithm on the Identification of 3D Printing Polymers Based on Hyperspectral CT Technology Combined with Artificial Neural Network.

Authors:  Zheng Fang; Renbin Wang; Mengyi Wang; Shuo Zhong; Liquan Ding; Siyuan Chen
Journal:  Materials (Basel)       Date:  2020-04-22       Impact factor: 3.623

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.